Back

Linear ablation at the mitral isthmus following mitral valve surgery

31 March 2025 (16:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Supraventricular tachycardia ablation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Kinan Kneizeh

South Nuremberg Clinic, Nuremberg (Germany)

6 More presentations in this session

Presentation thumbnail
Fluoroless catheter ablation of leftsided tachycardias in patients with cardiac implantable electronic devices: a single-centre retrospective study
Miss V. Podlogar (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of irrigated flex-tip catheters in AVNRT using 3D electroanatomical mapping
Mr E. Amigo Otero (Huelva, ES)
Abstract Slides Video
Presentation thumbnail
Catheter ablation of atypical left atrial flutter - Comparison of outcomes between pulsed field ablation and radiofrequency ablation
Doctor V. Spahiu (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Electroanatomic activation mapping for atrioventricular nodal reentry tachycardia ablation: a safe and innovative method in a new era
Doctor A. Mpatsouli (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Cavo-tricuspid isthmus dependent flutter ablation using a focal monopolar pulsed-field ablation catheter.
Doctor F. Farnir (Liege, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Supraventricular tachycardia ablation

The Event

Event poster

EHRA 2025

31 March 2025 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Acute impact of vein of marshall ethanol infusion combined with anatomical ablation validated by pacing in redo ablation of persistent atrial fibrillation
thumbnail
Congress Presentation
Live-in-the-Box: Marshall bundle-related atrial tachycardias
thumbnail
Congress Presentation
Vein of marshall ethanol infusion plus anatomical ablation versus pulmonary vein isolation alone for first ablation of persistent atrial fibrillation: long-term outcomes from the VOMALC-PeAF registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources